The Utility of a Population Approach in Drug-Drug Interaction Assessments: A Simulation Evaluation.

about

The Utility of a Population Approach in Drug-Drug Interaction Assessments: A Simulation Evaluation.

Item

http://www.wikidata.org/entity/Q50641094

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

The Utility of a Population Ap ...... ents: A Simulation Evaluation.

@en

The Utility of a Population Ap ...... ents: A Simulation Evaluation.

@nl

type

Item

label

The Utility of a Population Ap ...... ents: A Simulation Evaluation.

@en

The Utility of a Population Ap ...... ents: A Simulation Evaluation.

@nl

prefLabel

The Utility of a Population Ap ...... ents: A Simulation Evaluation.

@en

The Utility of a Population Ap ...... ents: A Simulation Evaluation.

@nl

P1476

The Utility of a Population Ap ...... ents: A Simulation Evaluation.

@en

P2093

Andrew T Chow

http://www.w3.org/2001/XMLSchema#string

Chuanpu Hu

http://www.w3.org/2001/XMLSchema#string

Diane D Wang

http://www.w3.org/2001/XMLSchema#string

Justin C Earp

http://www.w3.org/2001/XMLSchema#string

Manish Gupta

http://www.w3.org/2001/XMLSchema#string

Min Zhu

http://www.w3.org/2001/XMLSchema#string

Nastya Kassir

http://www.w3.org/2001/XMLSchema#string

William D Hanley

http://www.w3.org/2001/XMLSchema#string

Yanke Yu

http://www.w3.org/2001/XMLSchema#string

P2860

Assessment of the quality and quantity of drug-drug interaction studies in recent NDA submissions: study design and data analysis issues.

Statistical power calculations for mixed pharmacokinetic study designs using a population approach

Impact of infectious and inflammatory disease on cytochrome P450-mediated drug metabolism and pharmacokinetics

The conduct of in vitro and in vivo drug-drug interaction studies: a PhRMA perspective.

Pharmacokinetic drug-drug interaction potentials for therapeutic monoclonal antibodies: reality check.

Critical review of preclinical approaches to investigate cytochrome p450-mediated therapeutic protein drug-drug interactions and recommendations for best practices: a white paper.

Methods and strategies for assessing uncontrolled drug-drug interactions in population pharmacokinetic analyses: results from the International Society of Pharmacometrics (ISOP) Working Group.

Effects of interleukin-6 (IL-6) and an anti-IL-6 monoclonal antibody on drug-metabolizing enzymes in human hepatocyte culture.

Confirmatory analysis for phase III population pharmacokinetics.

The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective.

P304

1268-1278

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCPH.921

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28513856

http://www.w3.org/2001/XMLSchema#string